Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Update on CaPP3 in high risk populations

Prof Sir John Burn – Institute of Genetic Medicine, Newcastle, UK

Update on CaPP3 in high risk populations ( Prof Sir John Burn – Institute of Genetic Medicine, Newcastle, UK )

Surgical advances in colorectal cancer care

Prof Jaffer Ajani - University of Texas MD Anderson Cancer Center, Houston, USA

Surgical advances in colorectal cancer care ( Prof Jaffer Ajani - University of Texas MD Anderson Cancer Center, Houston, USA )

miRNA screening through nipple aspiration sampling

Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands

miRNA screening through nipple aspiration sampling ( Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands )

Breast cancer in the 21st century

Prof Debu Tripathy - MD Anderson Cancer Center, Texas, USA

Breast cancer in the 21st century ( Prof Debu Tripathy - MD Anderson Cancer Center, Texas, USA )

Review of olaparib for ovarian cancer

Dr Michel Vulfovich - Memorial Cancer Institute, Hollywood, Florida, USA

Review of olaparib for ovarian cancer ( Dr Michel Vulfovich - Memorial Cancer Institute, Hollywood, Florida, USA )

Lung cancer immunotherapy

Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA

Lung cancer immunotherapy ( Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA )

'Other' targets in lung cancer

Dr Edward Garon - David Geffen School of Medicine at the University of...

'Other' targets in lung cancer ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

Prof Michael Seckl - Imperial College London, London

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer? ( Prof Michael Seckl - Imperial College London, London )

Polycomb repressors and epigenetic therapy

Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK

Polycomb repressors and epigenetic therapy ( Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK )

DNA repair and mutations as targets for personalised therapy

Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA

DNA repair and mutations as targets for personalised therapy ( Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA )

The changing process of drug discovery and design

Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK

The changing process of drug discovery and design ( Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK )

Glioblastoma heterogeneity in circulating tumour DNA

Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Glioblastoma heterogeneity in circulating tumour DNA ( Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )

More from ecancer